Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018
Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march Source: Eur Respir Rev 2014; 23: 292-298 Year: 2014
Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults Source: International Congress 2016 – New findings in mucosal immunology Year: 2016
Peripheral blood TSLP (thymic stromal lymphopoietin) in children as a biomarker? Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021
IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015
Association of thymic stromal lymphopoietin gene polymorphisms with atopic status, pulmonary function and airway hyperresponsiveness in a Japanese adult asthmatic population Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013
FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells Source: Eur Respir J 2009; 33: 425-435 Year: 2009
Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Establishing the effects of chronic exposure to IL-9 alone and in combination with IL-13 on the differentiation of asthmatic and non-asthmatic paediatric bronchial epithelial cells Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Thymic stromal lymphopoietin (TSLP), an innate immunity initiator of Th2 inflammatory responses, is induced by viral stimuli in asthmatic epithelium. Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017
High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010